Remove Anxiety disorders Remove Definition Remove Pharmaceuticals
article thumbnail

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. The marketing of medical conditions has become a key plank of pharmaceutical industry marketing. Helping widen the definitions of disease is a key part of marketing those pharmaceutical products.

article thumbnail

Default Depression—How We Now Interpret Distress as Mental Illness

Mad in America

R egardless of the context and cause, distress is increasingly interpreted and diagnosed as a mental illnesscommonly clinical depression and/or anxiety disorder. Our understanding of key terms and definitions needs to be clear and consistent if our prevention efforts are to be effective.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

May Cause Side Effects–Radical Acceptance and Psychiatric Drug Withdrawal: An Interview with Brooke Siem

Mad in America

I’m diagnosing a depressive and anxiety disorder and recommending medication.” So I just thought that maybe I needed to change pharmaceuticals, not change who I was and my perspective. She has a book called Radical Acceptance and I definitely borrowed it from her and have learned a lot of the concepts from her too.

article thumbnail

The Trauma Craze: How the Expansion of Trauma Diagnoses Fueled Victimhood Culture

Mad in America

Later, DSM-III-R (1987) expanded the definition to include sexual assault, and DSM-IV (1994) emphasized individual responses like fear or helplessness. However, there’s another problem: Given psychiatry’s lack of definitive diagnostic tests, it has always been vulnerable to malingering and simulation.

article thumbnail

It’s Health’s Illusions I Recall, I Really Don’t Know Health at All

Mad in America

Academics even boast that EBM shackles the pharmaceutical industry. According to legal and clinical definitions of evidence, there is no evidence in company assays. Rather than give us a serenic, which many might feel was not unreasonable to take at times, doctors have to give us an anxiety disorder.

article thumbnail

Psychology, Personhood, and the Crisis of Neoliberalism: Jeff Sugarman on Theoretical and Critical Psychology

Mad in America

Beck: I can definitely relate to that story. In one of your articles on neoliberalism and psychological ethics, you discuss the striking increase in social anxiety diagnoses over the past 30 years. Sarah and I became interested in a similar question: Why, at this particular moment, did social anxiety disorder become an epidemic?